2024 annual financial data
BioMarin Pharmaceutical 2024 Net income growth
Direct answer
Net income growth was 154.62%.
Operating income was 484,214,000 USD and net income was 426,859,000 USD.
Operating cash flow was 572,841,000 USD.
Get free BioMarin Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,853,915,000 USD
- Operating income
- 484,214,000 USD
- Net income
- 426,859,000 USD
- Operating cash flow
- 572,841,000 USD